Jacob, J., Sha, J., Jansen, J., Tsang, Y., Hernandez, L. (2025). Model-based evaluation of clinical outcomes for ponatinib versus 2G TKIs in third-line chronic myeloid leukemia (CML). Blood. https://doi.org/10.1182/blood-2025-7952